Imara has opened applications for its second-annual “Real Impact” grants for community-based nonprofit organizations that support people with rare…
Diana Campelo Delgado
Diana holds a PhD in Biomedical Sciences, with specialization in genetics, from Universidade Nova de Lisboa, Portugal. Her work has been focused on enzyme function, human genetics and drug metabolism.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Diana Campelo Delgado
Imara is opening higher dose arms in two Phase 2b trials assessing the safety and efficacy of IMR-687,…
Global Blood Therapeutics (GBT) has opened its grant program — the Access to Excellent Care for Sickle Cell Patients…
Intellia Therapeutics has received a grant from the Bill & Melinda Gates Foundation to develop sickle cell…
The European Medicines Agency (EMA) has granted the designation of orphan drug to ARU-1801, an experimental gene therapy being…